From: Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
TIMP-1 expression
Negative (n = 92)
Positive (n = 14)
p
CA-125 GCIG Response
0.53
Response (n = 93)
80 (87%)
13 (93%)
Non-response (n = 13)
12 (13%)
1 (7%)